蛋白多肽肺部給藥研究進(jìn)展doc-資料下載頁
2025-07-15 22:34本頁面
【正文】 25 ( 45):427437.[6] Oliveira B F, Santana M H A, Re M I. Spraydried chitosan microspheres cross linked with d , lglyceraldehyde as a potential drug delivery system: preparation and characterization [J] .Braz J Chem Eng ,2005, 22（3): 353360.[7] HAYES R P,MUCHMORE D, SCHMITKE J. Effect of inhaled in sulin on patient2reported outes and treatment p reference in patients with type 1 diabetes [ J ]. Curr Med Res Op in, 2007, 23 (2) : 435242.[8]Wang J, Tabata Y, Morimoto K, et al. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats. J Controll Release, 2006, 113: 31 37.[9] Huang YY, Wang CH. Pulmonary delivery of insulin by lip somal carriers[J] . J Control Release, 2006,113(1):914.[10] Lu D, Hickey AJ. Liposomal dry powders as aerosols for pulmonary delivery of proteins[J] .AAPS Pharm Sci T ech, 2005,6(4):E641648.[11] Yamamoto H，Kuno Y，Sugimoto S，et al. Surface modifiedPLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions[J]. J Control Release，2005，102（2）：373.[12] 劉洪濤，尚明美，[J] .生物技術(shù)通訊, 2005,16( 5):577 9.[13] 朱珺. 蛋白質(zhì)和多肽類藥物修飾用聚乙二醇衍生物[J] .世界臨床藥物, 2007,28(10):628 31.[14]Codrom V,Vanderbist F,Verbeeek RK,et of parathyriod hormone(134)using inhalation drypowders in rats. J Pharm Sci,2003,92(5):938 7 / 7
教學(xué)課件相關(guān)推薦
鄂ICP備17016276號-1